Participate
Submit abstract
Abstract Submission Deadline: 23 May 2025
Oral and paper abstracts are now invited on the following topics. They should be submitted using the online abstract submission system opens in new tab/window.
Conference Topics
Systems Vaccinology
Vaccines Against STIs
Models for Vaccine Development and Evaluation
Pediatric Vaccines
Cancer Vaccines
Social and Political Impacts of Vaccination & Vaccine Policy
Vaccines Against Respiratory Viruses: Focus on Mucosal Immunity
One Health Vaccines
Vaccine Safety
Vaccines for older adults and strategies to tackle immunosenescence
Vaccine Technology
Hot Topics in Emerging Pathogens
Managing Vaccine Data
Veterinary Vaccines
You can submit as many abstracts to the conference for review as you would like. If, after the review by the committee, you have more than one paper accepted for the conference, you will need to register to attend and pay an additional paper fee for each additional paper (i.e., for the 2nd, 3rd, 4th papers – not the 1st). Please note this is for papers that you are the presenting author of, not papers that you are co-author of.
Successfully submitted abstracts will be acknowledged with an electronic receipt including an abstract reference number, which should be quoted in all correspondence. Allow at least 2 hours for your receipt to be returned to you.
For revisions or queries regarding papers already submitted
For revisions or queries regarding abstracts already submitted please contact the Conference Content Executive opens in new tab/window, (please do not email credit card information under any circumstances). If you do not receive acknowledgement for your abstract submission or you wish to make any essential revisions to an abstract already submitted, please DO NOT RESUBMIT your abstract, as this may lead to duplication. Please email the Conference Content Executive opens in new tab/window (please do not email credit card information under any circumstances) with details of any revisions or queries. Please quote your reference number if you have one. A condition of submission is that if accepted one of the authors will present at the conference.
JSV Session
We are excited to announce that a Joint Symposium with the Japanese Society of Vaccinology (JSV) and AMED-SCARDA will be held at the 19th Vaccine Congress on Sunday, 7 September 2025.
Date: Sunday, 7 September 2025
Time: 13:30 – 17:30
Title: Vaccine science and design for the pandemic preparedness
Tentative program:
13:30 – 13:45 | Opening Remarks: Takashi Nakano (President of JSV) Michinari Hamaguchi (SCARDA) |
13:45 – 14:45 | Session 1: Grand design platform and database for the development of innovative adjuvant and vaccine carrier |
14:45 – 15:15 | Coffee Break |
15:15 – 16:15 | Session 2: Innovative vaccine evaluation system for 100 days mission |
16:15 – 17:15 | Plenary talk: “Regulation of the germinal center B cell response to vaccination” Ali Ellebedy, Washington University in St. Louis, USA |
17:15 – 17:30 | Closing Remarks |
The Joint JSV / AMED-SCARDA Symposium is free to attend for registered conference attendees and JSV members. Sign-up is required via the registration system opens in new tab/window (JSV members will be given the option to sign up to the Symposium without having to register to the Congress).
Awards
The deadline for nominations has now passed.
Schneerson Robbins Award
Rachel Schneerson and John Robbins are known for their groundbreaking work and bold, visionary and imaginative leadership in the development and commercialization of the Hemophilus influenzae type b vaccine and bringing the vaccine to market, leading to the eradication of Hemophilus influenzae type b, typhoid, and pneumococcus.
The purpose of the award is to recognise an outstanding scientist in the field of Bacterial Vaccines.
The nomination should contain the name of your nominee, his/her CV, and a summary of his/her scientific merit and research impact. Unfortunately self-nominations cannot be accepted.
Please send nominations to Cinzia Mamberti, Conference Project Lead opens in new tab/window ([email protected] opens in new tab/window) with the subject heading “Vaccine 2025 - Schneerson Robbins Award”.
Deadline for nominations: 7 March 2025
The winner of the 2025 award will be invited to give a 30-minute Keynote lecture at the 19th Vaccine Congress in Kyoto, Japan, 7 – 10 September 2025. Registration will be complementary and a contribution towards flight and accommodation at the conference will also be provided.
The selected nominee will be contacted by the Organisers by 19 March 2025.
Previous recipients of the award:
2024: Galit Alter Moderna, USA
2023: Maria Elena Bottazzi, Baylor College of Medicine, USA
2022: Rino Rappuoli, GlaxoSmithKline Vaccines, Italy
2019: Kathryn M. Edwards, Director, Vanderbilt Vaccine Research Program, Vanderbilt University School of Medicine, USA
2018: Carol J. Baker, University of Texas Health Science Center, USA
2017: Rachel Schneerson, National Institutes of Health, USA
Jenner Award
Edward Jenner was an English doctor, the pioneer of smallpox vaccination and the father of immunology.
https://www.bbc.co.uk/history/historic_figures/jenner_edward.shtml opens in new tab/window
The purpose of the award is to recognise an outstanding scientist in the field of Vaccinology.
The nomination should contain the name of your nominee, his/her CV, and a summary of his/her scientific merit and research impact. Unfortunately self-nominations cannot be accepted.
Please send nominations to Cinzia Mamberti, Conference Project Lead opens in new tab/window ([email protected] opens in new tab/window) with the subject heading “Vaccine 2025 - Jenner Award”.
Deadline for nominations: 7 March 2025
The winner of the 2025 award will be invited to give a 20-minute Keynote lecture at the 19th Vaccine Congress in Kyoto, Japan, 7 – 10 September 2025. Registration will be complementary and a contribution towards flight and accommodation at the conference will also be provided.
The selected nominee will be contacted by the Organisers by 19 March 2025.
Previous recipients of the award:
2024: Kathleen Neuzil, Fogarty International Center, NIH, USA
2023: Robin Shattock, Imperial College London, UK
2022: Myron Levin, University of Colorado, USA
2019: Rino Rappuoli, Chief Scientist & Head of External Research and Development, GlaxoSmithKline Vaccines, USA
2018: Stanley A. Plotkin, University of Pennsylvania & Vaxconsult, USA
2017: John B Robbins, National Institutes of Health, USA
Early Career Researcher Award
The ECR Award will be presented to an exceptional young researcher in the field of Vaccines, ideally within the first 5 years of their career.
The nomination should contain a recent CV and a letter of support from an established colleague or professor. We are pleased to accept self-nominations for this award.
Please send nominations to Cinzia Mamberti, Conference Project Lead opens in new tab/window ([email protected] opens in new tab/window) with the subject heading “Vaccine 2025 - ECR Award”.
Deadline for nominations: 7 March 2025
The winner of the 2025 award will be invited to give a 20-minute Keynote lecture at the 19th Vaccine Congress in Kyoto, Japan, 7 – 10 September 2025. Registration will be complementary and a contribution towards flight and accommodation at the conference will also be provided.
The selected nominee will be contacted by the Organisers by 19 March 2025.
Previous recipients of the award:
2024: David Martinez, Yale University School of Medicine, USA
2022: Daniela Weiskopf, La Jolla Institute for Immunology, USA
Host Country Early Career Researcher Award
The ECR Award will be presented to an exceptional young researcher in the field of Vaccines and based in Japan, host country of the Vaccine 2025 Conference, ideally within the first 5 years of their career.
The nomination should contain a recent CV and a letter of support from an established colleague or professor. We are pleased to accept self-nominations for this award.
Please send nominations to Cinzia Mamberti, Conference Project Lead opens in new tab/window ([email protected] opens in new tab/window) with the subject heading “Vaccine 2025 – Host Country ECR Award”.
Deadline for nominations: 7 March 2025
The winner of the 2025 award will be invited to give a 20-minute Keynote lecture at the 19th Vaccine Congress in Kyoto, Japan, 7 – 10 September 2025. Registration will be complementary and a contribution towards flight and accommodation at the conference will also be provided.
The selected nominee will be contacted by the Organisers by 19 March 2025.
Please do not email credit card information under any circumstances.
Conference Dinner
Join us for the Conference Dinner at Heian Jingu Shrine Restaurant & Banquet Hall opens in new tab/window on Tuesday, 9September 2025, for the opportunity to network in a relaxed environment.
Heian Jingu Shrine Restaurant & Banquet Hall is located within the shrine grounds of the Heian Jingu Shrine, one of the most famous and prestigious shrines in Japan, built in 1895 for the 1,100th anniversary of the relocation of the capital city to Heiankyo. The interior boasts traditional Japanese architecture and amazing views of the scenic Shin-en Garden. The garden was designed by the Japanese Government as a ‘Place of Scenic Beauty’. In contrast to the magnificent image of the vermilion shrine gate (torii) and gorgeous shrine buildings of the Heian Jingu Shrine, the view of the vast garden gives the venue a calm and quiet atmosphere.
Tickets are priced at US$70 + VAT 10% = US$77 and include:
A sit-down meal
Wine, beer and soft drinks
Shrine garden stroll before the meal
Please make us aware of any dietary requirements upon registering.
Places are limited so please book early via the online registration system. opens in new tab/window